Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 05, 2026
DataAggregated Company Financials
Companies6
- 7D3.7%
- 3M-17.7%
- 1Y-27.4%
- YTDn/a
In the last week, the Drug Retail industry is up 5.2%, with JD Health International up 3.3%. Meanwhile, Lung Fung Group Holdings actually underperformed within the industry, shrinking 5.4% in the last week. However, the industry is down 25% over the past year. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 05 Aug 2026 | HK$202.6b | HK$143.6b | HK$8.7b | 31.8x | 23.2x | 1.4x |
| Fri, 03 Jul 2026 | HK$178.2b | HK$142.7b | HK$8.7b | 28.6x | 20.5x | 1.2x |
| Sun, 31 May 2026 | HK$204.3b | HK$143.2b | HK$8.7b | 34.7x | 23.4x | 1.4x |
| Tue, 28 Apr 2026 | HK$245.8b | HK$140.6b | HK$8.6b | 43.4x | 28.4x | 1.7x |
| Thu, 26 Mar 2026 | HK$270.8b | HK$140.3b | HK$8.3b | 50.1x | 32.6x | 1.9x |
| Sat, 21 Feb 2026 | HK$315.6b | HK$129.5b | HK$6.9b | 44.8x | 45.5x | 2.4x |
| Mon, 19 Jan 2026 | HK$370.6b | HK$128.0b | HK$6.9b | 50.9x | 54.1x | 2.9x |
| Wed, 17 Dec 2025 | HK$301.4b | HK$126.3b | HK$6.8b | 39x | 44.5x | 2.4x |
| Fri, 14 Nov 2025 | HK$342.0b | HK$122.6b | HK$6.2b | 60.6x | 55.5x | 2.8x |
| Sun, 12 Oct 2025 | HK$346.9b | HK$122.1b | HK$6.1b | 64.1x | 56.5x | 2.8x |
| Tue, 09 Sep 2025 | HK$363.0b | HK$122.4b | HK$6.2b | 66.8x | 59x | 3x |
| Thu, 07 Aug 2025 | HK$285.3b | HK$115.3b | HK$4.5b | 51.8x | 63.4x | 2.5x |
| Sat, 05 Jul 2025 | HK$229.6b | HK$115.6b | HK$4.5b | 43.3x | 50.8x | 2x |
| Mon, 02 Jun 2025 | HK$225.6b | HK$114.9b | HK$4.5b | 46.7x | 50.3x | 2x |
| Wed, 30 Apr 2025 | HK$223.2b | HK$110.1b | HK$4.2b | 61.7x | 53.7x | 2x |
| Fri, 28 Mar 2025 | HK$213.2b | HK$110.5b | HK$4.2b | 61.5x | 51.1x | 1.9x |
| Sun, 23 Feb 2025 | HK$239.6b | HK$104.1b | HK$3.6b | 58.5x | 66.5x | 2.3x |
| Tue, 21 Jan 2025 | HK$160.3b | HK$103.4b | HK$3.6b | 38.2x | 44.8x | 1.6x |
| Thu, 19 Dec 2024 | HK$159.4b | HK$103.6b | HK$3.6b | 38.1x | 44.4x | 1.5x |
| Sat, 16 Nov 2024 | HK$170.6b | HK$104.7b | HK$3.6b | 39.1x | 47.1x | 1.6x |
| Mon, 14 Oct 2024 | HK$181.8b | HK$105.4b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Wed, 11 Sep 2024 | HK$135.7b | HK$105.0b | HK$3.3b | 36.4x | 40.7x | 1.3x |
| Fri, 09 Aug 2024 | HK$137.3b | HK$103.0b | HK$2.4b | 41.4x | 56.9x | 1.3x |
| Sun, 07 Jul 2024 | HK$137.7b | HK$101.9b | HK$2.4b | 41.8x | 57.7x | 1.4x |
| Tue, 04 Jun 2024 | HK$157.7b | HK$102.3b | HK$2.4b | 46.7x | 65.8x | 1.5x |
| Thu, 02 May 2024 | HK$152.9b | HK$103.7b | HK$2.3b | 45.7x | 65.7x | 1.5x |
| Sat, 30 Mar 2024 | HK$158.8b | HK$104.0b | HK$2.3b | 47.9x | 68x | 1.5x |
| Mon, 26 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,456,103,459.27 | 58.2x | -120.8x | 1.7x |
| Wed, 24 Jan 2024 | HK$162.5b | HK$105.4b | -HK$1,460,866,080.00 | 52.2x | -111.2x | 1.5x |
| Fri, 22 Dec 2023 | HK$203.1b | HK$105.7b | -HK$1,464,003,846.00 | 63.2x | -138.7x | 1.9x |
| Sun, 19 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,792,415.00 | 86.2x | -120.6x | 2.1x |
| Tue, 17 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Thu, 14 Sep 2023 | HK$230.5b | HK$102.9b | -HK$1,683,528,739.00 | 83x | -136.9x | 2.2x |
| Sat, 12 Aug 2023 | HK$269.5b | HK$95.6b | -HK$4,147,877,661.00 | 124.6x | -65x | 2.8x |
Price to Earnings Ratio
-65x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.4x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.83% | |
| Consumer Staples | 0.60% | |
| Food and Staples Retail | 1.27% | |
| Drug Retail | 3.69% | |
| Food Distributors | 2.10% | |
| Food Retail | -1.81% | |
| Big Box Super Stores | -7.17% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.20 | 3.3% +HK$4.0b | -23.1% | PE20x | |
| 241 Alibaba Health Information Technology | HK$3.59 | 4.7% +HK$2.6b | -28.1% | PE25.8x | |
| 1833 Ping An Healthcare and Technology | HK$7.83 | 4.8% +HK$765.6m | -35.0% | PE37.8x |